| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US22686900P | 2000-08-22 | 2000-08-22 | |
| US24062700P | 2000-10-13 | 2000-10-13 |
| Publication Number | Publication Date |
|---|---|
| PL365744A1true PL365744A1 (en) | 2005-01-10 |
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL01365744APL365744A1 (en) | 2000-08-22 | 2001-08-21 | Methods of drug delivery to hepatocytes and treatment of flaviviridae infections |
| Country | Link |
|---|---|
| EP (1) | EP1313469A1 (en) |
| JP (1) | JP2004506684A (en) |
| KR (1) | KR20030040416A (en) |
| CN (1) | CN1447692A (en) |
| AU (1) | AU2001292557A1 (en) |
| BR (1) | BR0113388A (en) |
| CA (1) | CA2415793A1 (en) |
| CZ (1) | CZ2003308A3 (en) |
| HU (1) | HUP0302884A2 (en) |
| IL (1) | IL154167A0 (en) |
| MX (1) | MXPA03001529A (en) |
| NO (1) | NO20030794L (en) |
| PL (1) | PL365744A1 (en) |
| RU (1) | RU2003102607A (en) |
| WO (1) | WO2002015904A1 (en) |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003037908A1 (en)* | 2001-10-31 | 2003-05-08 | Ribapharm Inc. | Antiviral combination therapy and compositions |
| US6811777B2 (en) | 2002-04-13 | 2004-11-02 | Allan Mishra | Compositions and minimally invasive methods for treating incomplete connective tissue repair |
| US7608258B2 (en) | 2002-04-13 | 2009-10-27 | Allan Mishra | Method for treatment of tendinosis using platelet rich plasma |
| US20050182252A1 (en) | 2004-02-13 | 2005-08-18 | Reddy K. R. | Novel 2'-C-methyl nucleoside derivatives |
| US20100112081A1 (en) | 2008-10-07 | 2010-05-06 | Bioparadox, Llc | Use of platelet rich plasma composition in the treatment of cardiac conduction abnormalities |
| US20140356893A1 (en) | 2013-06-04 | 2014-12-04 | Allan Mishra | Compositions and methods for using platelet-rich plasma for drug discovery, cell nuclear reprogramming, proliferation or differentiation |
| EP3105238A4 (en) | 2014-02-13 | 2017-11-08 | Ligand Pharmaceuticals, Inc. | Prodrug compounds and their uses |
| EP3164136A4 (en) | 2014-07-02 | 2018-04-04 | Ligand Pharmaceuticals, Inc. | Prodrug compounds and uses therof |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3984396A (en)* | 1971-06-01 | 1976-10-05 | Icn Pharmaceuticals, Inc. | 1-(β,-D-ribofuranosyl)-1,2,4-triazole acid esters |
| US5959077A (en)* | 1993-05-26 | 1999-09-28 | Laboratori Balducci S.P.A. | Hepatotropic conjugates of antiviral drugs carriers thereof and pharmaceutical compositions containing them |
| Publication number | Publication date |
|---|---|
| BR0113388A (en) | 2004-02-25 |
| NO20030794D0 (en) | 2003-02-20 |
| IL154167A0 (en) | 2003-07-31 |
| WO2002015904A1 (en) | 2002-02-28 |
| CN1447692A (en) | 2003-10-08 |
| RU2003102607A (en) | 2004-07-27 |
| KR20030040416A (en) | 2003-05-22 |
| EP1313469A1 (en) | 2003-05-28 |
| WO2002015904B1 (en) | 2002-07-04 |
| CZ2003308A3 (en) | 2004-03-17 |
| AU2001292557A1 (en) | 2002-03-04 |
| JP2004506684A (en) | 2004-03-04 |
| CA2415793A1 (en) | 2002-02-28 |
| MXPA03001529A (en) | 2004-04-02 |
| HUP0302884A2 (en) | 2003-12-29 |
| NO20030794L (en) | 2003-04-22 |
| Publication | Publication Date | Title |
|---|---|---|
| HUP0301121A3 (en) | Topical pharmaceutical formulations and methods of treatment | |
| PL372925A1 (en) | Prevention and treatment of restenosis by local administration of drug | |
| IL215891A (en) | Hepatitis c virus serine protease inhibitors, pharmaceutical compositions comprising them and use thereof in the preparation of medicaments for the treatment of hepatitis c virus infections | |
| HUP0500003A3 (en) | Improvements in and relating to medicament injection apparatus | |
| GB2412318B (en) | Drug delivery particles and methods of treating particles to improve their drug delivery capabilities | |
| EE05149B1 (en) | Biar acarboxamides, process for their preparation, pharmaceutical composition containing them and their use in therapy | |
| DK1183029T3 (en) | Pharmaceutical preparation containing diamorphine and vitamin E and its use in the treatment of opiate abuse | |
| HUP0300746A3 (en) | Proline derivatives and use thereof as drugs | |
| AU6118001A (en) | Combination therapeutic compositions and methods of use | |
| AU3898700A (en) | Treatment of acute headaches and chronic pain using rapidly-cleared anesthetic drug at sub-anesthetic dosages | |
| IL160754A0 (en) | Dosage form, device and methods of treatment | |
| HUP0301892A3 (en) | Pharmaceutical compositions for treatment of sexual dysfunction and their preparation | |
| EE200200271A (en) | Combinations of medicinal products and their use | |
| IL154167A0 (en) | Methods of drug delivery to hepatocytes and treatment of flaviviridae infections | |
| EP1356812A4 (en) | Medicines for treatment and prevention of neurogenic pain | |
| GB9912639D0 (en) | Improvements in and relating to treatment of respiratory conditions | |
| HK1053976A (en) | Methods of drug delivery to hepatocytes and treatment of flaviviridae infections | |
| GB0003201D0 (en) | Method to potentiate the therapeutic efficacy of taxane and derivatives thereof | |
| IL155819A0 (en) | Methods of treatment comprising administration of substance p | |
| GB0007217D0 (en) | Materials and methods relating to the treatment of leukaemias | |
| HUP0301119A3 (en) | Biologically active agent and drug | |
| AU2002322424A8 (en) | Novel methods and formulations for administration of active agents | |
| GB0007788D0 (en) | Method to evaluate the therapeutic and toxic effects related to drug administration | |
| ATE371446T1 (en) | COMPOSITIONS FOR PREVENTING ADHESION | |
| GB0120124D0 (en) | Effect of timing and duration of administration of amp 579 on reperfusion injury in rabbit heart |
| Date | Code | Title | Description |
|---|---|---|---|
| DISC | Decisions on discontinuance of the proceedings (taken after the publication of the particulars of the applications) |